ELANE:an emerging lane to selective anticancer therapy

查看全文 作　　者：Boqiang [1]Peng;Jiankun [1]Hu;Xianghui [2]Fu

机构地区：[1]Laboratory of Gastric Cancer and Department of Gastrointestinal Surgery,State Key Laboratory of Biotherapy and Cancer Center,West China Hospital,Sichuan University and Collaborative Innovation Center of Biotherapy,Chengdu,Sichuan,China;[2]Division of Endocrinology and Metabolism,State Key Laboratory of Biotherapy and Cancer Center,West China Hospital,Sichuan University and Collaborative Innovation Center of Biotherapy,Chengdu,Sichuan,China

出　　处：《Signal Transduction and Targeted Therapy》索引2021年第6卷第11期,共2页

基　　金：This work was supported by the National Natural Science Foundation of China(81970561);the Ministry of Science and Technology of China(2018ZX09201018-005);the 1.3.5 Project for Disciplines of Excellence,West China Hospital,Sichuan University(ZYJC18049). 摘　　要：Recently,Cui et al.1 revealed that neutrophil elastase(ELANE)can selectively kill a wide range of cancer cells while sparing proximal non-cancer cells and significantly attenuate tumorigenesis,suggesting a promising selective and broad anticancer strategy. 关键词：CANCER PROXIMAL

相关文献

参考文献（5）
引证文献（2）
耦合文献（0）

参考文献(5)

引证文献(2)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

ELANE:an emerging lane to selective anticancer therapy

参考文献(5)

引证文献(2)

用户提示